Sarepta Therapeutics, Inc. (SRPT)
23.77
+6.16
(+34.98%)
USD |
NASDAQ |
Mar 25, 16:00
23.55
-0.22
(-0.93%)
After-Hours: 20:00
Sarepta Therapeutics Free Cash Flow : -332.39M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Keros Therapeutics, Inc. | 105.95M |
| Merck & Co., Inc. | 12.36B |
| PTC Therapeutics, Inc. | 411.18M |
| REGENXBIO, Inc. | -126.38M |
| Gilead Sciences, Inc. | 9.456B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 126.93M |
| Cash from Investing (Quarterly) | 96.21M |
| Cash from Financing (Quarterly) | -34.94M |
| Free Cash Flow Per Share (Quarterly) | 1.176 |
| Free Cash Flow to Equity (Quarterly) | 333.84M |
| Free Cash Flow to Firm (Quarterly) | 144.28M |
| Free Cash Flow Yield | -13.68% |